Home | Icebreaker

Sign up or Log in

Teams

System

Home | Icebreaker

Home

Certara's transformative drug development solutions include data-driven modelling, AI and predictive simulation. Accelerate your development process for good

13 members

Contact info

Link

certara.com

Members

•

Clinical Research Manager

•

Associate Director, Business Development at Otsuka

•

Accomplished technology leader with a 25-year track record of successful strategic and tactical experience transforming organizations through highly engaged teams and implementation of thoughtful technologies. Creative visionary with a steadfast commitment to excellence driving IT to become an integral part of the organization. Deep expertise leading global organizations undergoing rapid growth and change in response to technology shifts and organizational change. Demonstrated ability to instill a common vision and develop a dynamic team based on trust and mutual respect.

•

Accomplished, strategically focused board director and private equity operating executive working broadly across the healthcare space, with a demonstrated 35-year track record of building high-growth public and private healthcare businesses to market leadership and delivering superior results. • Experienced Board Director and Private Equity Operating Partner: Served as director/chairman on multiple PE-backed healthcare boards and six public boards including Fortune 500 company. Partnered with select private equity groups (including EQT, Nordic Capital, Tailwind, Court Square, Linden, Providence Equity) to establish healthcare investment themes, source and diligence investment opportunities, and as active portfolio company board chairman/director drive growth and build shareholder value. Primary board experience and focus on strategy and corporate development, as well as organizational development, governance and compensation. • High-Performance Public Co Chairman & CEO: Took inVentiv Health (Nasdaq: VTIV) public, and over the next decade built and transformed it into a global market leader with $1.1 billion revenue and 7,000+ employees. Grew revenues 38% p.a., Adj. EBITDA 43% p.a., beat analyst consensus for 23 consecutive quarters, drove stock price appreciation by 50+% p.a. (2002-08). Led inVentiv’s subsequent go-private sale to Thomas H. Lee Partners. inVentiv Health and INC Research subsequently merged to form Syneos Health. • Business Builder: Track record of building market leaders by strengthening the leadership team, enhancing organizational effectiveness, driving strong organic growth, and in parallel pursing an aggressive, targeted acquisition strategy to enhance competitive position and drive in-organic growth. • Healthcare Strategist: Broad perspective and long-term track record as a Board Director, CEO, and Strategist broadly across the healthcare space. An active catalyst and change agent for 35+ years, evolving the strategic direction and business models at multiple mid-sized and large healthcare companies. • Global Perspective and Sensitivity: Built and worked with multiple global businesses; and bring a global perspective and sensitivity from having grown up in Israel and Europe and educated in the US.

•

Senior Employee Onboarding Specialist | Human Resources Operations

Daniel D. Corcoran

•

General Counsel at Certara (Nasdaq: CERT)

Stephen Pollard

•

Senior Director, Software Implementation

•

CEO at Acoer. Formerly Chief Software Architect at CDC. Open science and private AI software to improve clinical research and public health reporting.

•

Experienced Scientist with a demonstrated history of working in healthcare, MedTech, and academic research. Skilled in Medical Devices, Biotechnology, Health Technology, Business French, python, and R. Strong research professional recently graduated with a second Master's degree in Data Science from Johns Hopkins with Honors.

•

Quantitative Medicine Leader @ Critical Path Institute (C-Path) | Modeling, Simulation